Cyclophosphamide-pomalidomide combination alters the tumour cell secretome and enhances the anti-myeloma activity of elotuzumab through NK cell-mediated cytotoxicity
Fields of Study & Subjects
Multiple Myeloma Research and Treatments
Immune Cell Function and Interaction
Monoclonal and Polyclonal Antibodies Research
Publication details
- Journal / source
- Research Repository UCD (University College Dublin)
- Publication date
- 25 February 2026
- Language
- EN